Ajay Wasan, MD, Msc

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Ajay Wasan, MD, Msc sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).

4 total trials 1 currently recruiting 2 completed upper quartile by trial count

Ajay Wasan, MD, Msc: 4 sponsored US clinical trials, 1 recruiting.

Ajay Wasan, MD, Msc sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Negative Affectivity, with 1 trials.

Upper-quartile sponsor footprint

Ajay Wasan, MD, Msc sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Ajay Wasan, MD, Msc pipeline

1 recruiting of 4 indexed (25% open); 2 completed (50%).

Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).

Top condition: Negative Affectivity (1 trial), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Ajay Wasan, MD, Msc: open-pipeline peers nationwide

Peers matched on 4 registered trials and 25% open enrollment, not the therapeutic-area sidebar.

Ajay Wasan, MD, Msc sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 3456789 0%20%40%60%80% Total trials Recruiting share Ajay Wasan, MD, Msc4D pharma60 Degrees PharmaceuticalsA2 BiotherapeuticsAbdul Latif Jameel Poverty Action LabAB ScienceAbbott Point of CareAccutar BiotechnologyAdrienne G. Waks
Ajay Wasan, MD, Msc sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Ajay Wasan, MD, Msc sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 4 trials (± recruiting share)

Sponsors near 25% open enrollment (± trial volume)

What to do with this Ajay Wasan, MD, Msc page

4 registered trials is a research-attention snapshot, not an endorsement of Ajay Wasan, MD, Msc or any single study.

  • 1 of Ajay Wasan, MD, Msc's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Negative Affectivity is the condition Ajay Wasan, MD, Msc studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Negative Affectivity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Ajay Wasan, MD, Msc pipeline card: 4 registered trials from official public datasets.Report a data error.